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Introduction 
Present methods to image microvascular flow involve mainly the intravenous administration of a bolus injection from a paramagnetic contrast 
followed by the rapid, time-resolved, MR imaging of the kinetics of its first pass through the microvasculature of the imaged slice 1,2. This approach 
relies both on the chemical nature of the contrast agent used and on the inherent properties of the MR technique implemented. Most protocols 
combine the use of conventional contrast agents as Gd(III)DTPA (Bayer-Schering, Berlin, DE) or Gd(III)DOTA (Guerbet, Paris, FR, Bracco, Torino, 
IT) and rapid Echo Planar MR imaging methods to resolve in time the transit of the bolus of contrast agent through the imaging slice. In the case of 
the brain, analysis of the kinetic curves allows for the determination of the blood volume (CBV), blood flow (CBF), mean transit time (MTT) and 
eventually capillary permeability3. In this line Dy-complexes have been proposed to measure cerebral blood volume and to delineate healthy and 
damaged tissues by MRI4. On the other hand, dynamic susceptibility contrast magnetic resonance imaging (DSC-MRI) has already proven to be of 
clinical value, in order to distinguish between different tumor types of the human brain5. In this work we show the comparative results obtain in bolus 
track measurements performed in a high grade glioma rat model, using Gd- and Dy-containing compound as T2* contrast agents. Our main goal is to 
establish an optimal method to check the effectiveness of antiangiogenic therapies in high and low grade glioma murine models. 
 
Methods 
High grade gliomas were induced in Wistar rats (200-220 g) by stereotaxic injection of C6 cells in the right caudate nucleus. MRI evaluations were 
carried out between 21-25 days after the injection, in an horizontal 7T system (Bruker Pharmascan®) with a 1H selective birdcage resonator of 38 
mm. Animals were anesthetized with isofluorane 2% in oxygen, placed in a heated probe and physiologically monitored. Perfusion weighted imaging 
studies were performed using single-shot EPI acquisition and a solution of 0.3 M Gd-DTPA (Magnevist®) or 0.125 M Dy-DTPA (home made). The 
contrast agent was injected in the tail vein as a bolus (1 mL/kg bw) 10 seconds after starting acquisition. Both lanthanide complexes were assayed in 
the same animal, injecting Dy before because it has less appreciable effects on T1 than Gd, and waiting 3h until Gd injection. Acquisition parameters 
were the following: TR= 250 ms, TE = 7 ms, Av = 1, flip angle = 30o, acquisition matrix = 64×80 corresponding to an in-plane resolution of 594x475 
μm2, number of repetitions = 150, total acquisition time = 38 seconds. Parametric perfusion maps (CBF, CBV and MTT) were generated on a pixel 
by pixel basis. Data were analyzed in a PC platform with a software application written in house (MatLab R2007a). In order to compute the perfusion 
maps, pixel time-evolution signals were obtained, and the values corresponding to the first seconds of each temporal series were considered to set the 
basal level. The following expression was fitted: ΔR2*(t) = -k.ln(S(t)/S0(t)). Parametric maps were obtained for six slices (1.5 mm slice thickness) in 
each animal and four different regions (peripheral tumor, core tumor, white matter and cortex) in every case. 
 
Results and Discussion 
In the CBF, CBV and MTT maps obtained, we selected manually four brain regions containing at least 20 pixels each and yielding a value for every 
slice and every rat. Exactly the same pixels were analyzed both in Gd and Dy studies. Figure 1 summarizes the mean parametric data comparing 
measured either Gd-DTPA or Dy-DTPA. It can be noted that less quantity of paramagnetic metal leads more appreciable results using Dy- than Gd- 
complexe as contrast agent. Also, figure 1 shows higher absolute values in the parametric perfusion studies employing Dy, and a higher relative value 
when you compared regions to each other. On the other hand, in both DSC-MRI studies it can be appreciated lower CBF and CBV values in the core 
tumor than in other regions, similar values in peripheral tumor and white matter and the highest values in the brain cortex. MTT values are lower in 
the core tumor and similar in the other areas although in this case differences are more clearly estimated when Gd is employed.  
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a) CBF values employing either Gd or Dy-DTPA as T2* CA 
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b) CBV values employing either Gd or Dy-DTPA as T2* CA
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c) MTT values employing either Gd or Dy-DTPA as T2* CA 
Figure 1. Mean results obtained in DSC-MRI studies carried out in a high grade glioma rat model using two paramagnetic complexes as susceptibility contrast agent 
 
Conclusions 
Our results show that the use of Dy as paramagnetic susceptibility contrast agent in DSC MRI studies yields higher effects in perfusion parameters 
than the use of Gd. Dy complexes remain then as a better choice in perfusion MRI analysis in brain tumors because of their higher influence in T2 of 
the tissues. In the present glioma rat model that a this time point (21-25 days after injection of C6 cells) the core of the tumor is necrosed, so CBF and 
CBV are very low, and even peripheral tumor is not as well perfused as the brain cortex. The future steps in this study will be analyzing the results in 
the early stages of the tumor growth, when the tumor probably has an active neovascularization process and no necrosis appears yet.  
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